NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.

Published

Journal Article

The NCCN Clinical Practice Guidelines in Oncology for Bladder Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with bladder cancer. These NCCN Guidelines Insights discuss important updates to the 2018 version of the guidelines, including implications of the 8th edition of the AJCC Cancer Staging Manual on treatment of muscle-invasive bladder cancer and incorporating newly approved immune checkpoint inhibitor therapies into treatment options for patients with locally advanced or metastatic disease.

Full Text

Duke Authors

Cited Authors

  • Flaig, TW; Spiess, PE; Agarwal, N; Bangs, R; Boorjian, SA; Buyyounouski, MK; Downs, TM; Efstathiou, JA; Friedlander, T; Greenberg, RE; Guru, KA; Hahn, N; Herr, HW; Hoimes, C; Inman, BA; Jimbo, M; Kader, AK; Lele, SM; Meeks, JJ; Michalski, J; Montgomery, JS; Pagliaro, LC; Pal, SK; Patterson, A; Petrylak, DP; Plimack, ER; Pohar, KS; Porter, MP; Preston, MA; Sexton, WJ; Siefker-Radtke, AO; Tward, J; Wile, G; Johnson-Chilla, A; Dwyer, MA; Gurski, LA

Published Date

  • September 2018

Published In

Volume / Issue

  • 16 / 9

Start / End Page

  • 1041 - 1053

PubMed ID

  • 30181416

Pubmed Central ID

  • 30181416

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2018.0072

Language

  • eng

Conference Location

  • United States